Peptide glossary · Body and lab measures
MASH
Checked against National Institute of Diabetes and Digestive and Kidney Diseases (NIH)Published by PepVault
MASH, also called NASH, is the form of fatty liver disease in which the liver is inflamed and damaged, not only fatty.
What it means
The inflammation can scar the liver over time, and the scarring can lead to cirrhosis. Semaglutide, as Wegovy, is FDA-approved for MASH with moderate to advanced scarring, and GLP-1 and glucagon dual agonists such as efinopegdutide are being developed for it.
Why it matters when you track peptides
MASH is followed with blood tests, scans and biopsies, so the dates of those results are the record that shows change.
